NCT04883736 - A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris | Biotech Hunter

Enrollment

973

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

April 16, 2021

Study Completion Date

April 16, 2021

Conditions

Acne Vulgaris

Interventions

DRUG

Tretinoin Gel Microsphere, 0.1%

The study medication will be self-applied topically, on the affected areas of the face lightly, once daily in the evening, avoiding contact with the mouth, eyes, and other mucous membranes for 84 consecutive days.

DRUG

RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1%

The study medication will be self-applied topically, on the affected areas of the face lightly, once daily in the evening, avoiding contact with the mouth, eyes, and other mucous membranes for 84 consecutive days.

DRUG

Placebo Control

The study medication will be self-applied topically, on the affected areas of the face lightly, once daily in the evening, avoiding contact with the mouth, eyes, and other mucous membranes for 84 consecutive days.

Trial Locations (1)

28217

Catawba Research, LLC, Charlotte